Cytotoxic drugs in treatment of nonmalignant diseases.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D003093:Colitis, Ulcerative / Q000188:drug therapy; D003424:Crohn Disease / Q000188:drug therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007239:Infections / Q000188:drug therapy; D008105:Liver Cirrhosis, Biliary / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000188:drug therapy; D009879:Ophthalmia, Sympathetic / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D013866:Thioguanine; D014605:Uveitis / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D002699:Chlorambucil; D003520:Cyclophosphamide; D015122:Mercaptopurine; D013866:Thioguanine; D001379:Azathioprine; D008727:Methotrexate